Robert Shickel

Shickel-linkedin.6905

My Chronic Cancer LLC

2023

Technologies

Digital Health

Indication

Disease surveillance

Hematology

Oncology

My Chronic Cancer LLC | Today our InSite system is pre-FDA. InSite increases cancer patient survival and lowers direct front-end costs. InSite’s
targeted worldwide cloud market is 450M+ cancer patients.

Newsletter Signup

"*" indicates required fields

This field is for validation purposes and should be left unchanged.

Corporate Supporters

Program of

Initiated by